Lipid-polycaprolactone Core-shell Hybrid Nanoparticles for Controlled Delivery of Nateglinide. Asian Journal of Pharmaceutics (AJP), [S. l.], v. 15, n. 2, 2021. DOI: 10.22377/ajp.v15i2.4059. Disponível em: https://www.asiapharmaceutics.info/index.php/ajp/article/view/4059. Acesso em: 15 apr. 2026.